Chen X - Search Results

1

Inhibitory effect of the novel tyrosine kinase inhibitor DCC-2036 on triple-negative breast cancer stem cells through AXL-KLF5 positive feedback loop.

Shen Y, Zhu Q, Xiao M, Yin L, Feng W, Feng J, He J, Li P, Chen X, Ding W, Zhong J, Zeng Z, Xie Z, Liu J, Zu X. Shen Y, et al. Among authors: chen x. Cell Death Dis. 2022 Aug 30;13(8):749. doi: 10.1038/s41419-022-05185-x. Cell Death Dis. 2022. PMID: 36042208 Free PMC article.

2

Axl inhibitors as novel cancer therapeutic agents.

Shen Y, Chen X, He J, Liao D, Zu X. Shen Y, et al. Among authors: chen x. Life Sci. 2018 Apr 1;198:99-111. doi: 10.1016/j.lfs.2018.02.033. Epub 2018 Feb 27. Life Sci. 2018. PMID: 29496493 Review.

3

Therapeutic activity of DCC-2036, a novel tyrosine kinase inhibitor, against triple-negative breast cancer patient-derived xenografts by targeting AXL/MET.

Shen Y, Zhang W, Liu J, He J, Cao R, Chen X, Peng X, Xu H, Zhao Q, Zhong J, Ding W, Lei X, Jiang Y, Zu X. Shen Y, et al. Among authors: chen x. Int J Cancer. 2019 Feb 1;144(3):651-664. doi: 10.1002/ijc.31915. Epub 2018 Nov 7. Int J Cancer. 2019. PMID: 30289981

4

Knockdown of ZBTB7A inhibits cell proliferation of breast cancer through regulating the ubiquitination of estrogen receptor alpha.

Xiao X, Shen Y, Yin L, He J, Ni X, Luo G, Chen X, Zhu W, Zhong J, Liu J, Peng X, Zu X. Xiao X, et al. Among authors: chen x. Life Sci. 2019 Dec 15;239:117042. doi: 10.1016/j.lfs.2019.117042. Epub 2019 Nov 9. Life Sci. 2019. PMID: 31715186

5

Self-Renewal Signalling Pathway Inhibitors: Perspectives on Therapeutic Approaches for Cancer Stem Cells.

Zhu Q, Shen Y, Chen X, He J, Liu J, Zu X. Zhu Q, et al. Among authors: chen x. Onco Targets Ther. 2020 Jan 16;13:525-540. doi: 10.2147/OTT.S224465. eCollection 2020. Onco Targets Ther. 2020. PMID: 32021295 Free PMC article. Review.

6

Tumorigenesis and Progression As A Consequence of Hypoxic TME：A Prospective View upon Breast Cancer Therapeutic Targets.

Chen X, Wu C, Zhong J, Shen Y, Zu X. Chen X, et al. Exp Cell Res. 2020 Oct 15;395(2):112192. doi: 10.1016/j.yexcr.2020.112192. Epub 2020 Jul 30. Exp Cell Res. 2020. PMID: 32738345 Review.

7

LRRC4 mediates the formation of circular RNA CD44 to inhibitGBM cell proliferation.

Feng J, Ren X, Fu H, Li D, Chen X, Zu X, Liu Q, Wu M. Feng J, et al. Among authors: chen x. Mol Ther Nucleic Acids. 2021 Aug 26;26:473-487. doi: 10.1016/j.omtn.2021.08.026. eCollection 2021 Dec 3. Mol Ther Nucleic Acids. 2021. PMID: 34631278 Free PMC article.

8

Colorectal mucinous adenocarcinoma indicates a meaningful subtype: A whole genome sequencing study.

Xu Y, Chen X, Chen Y, Wu X, Fang Q, Tan X, Li S, Huang Q, Zu X, Fu K, Xiao S. Xu Y, et al. Among authors: chen x, chen y. Clin Transl Med. 2023 Apr;13(4):e1246. doi: 10.1002/ctm2.1246. Clin Transl Med. 2023. PMID: 37186506 Free PMC article. No abstract available.

9

FUNDC2, a mitochondrial outer membrane protein, mediates triple-negative breast cancer progression via the AKT/GSK3β/GLI1 pathway.

Yin L, Cao R, Liu Z, Luo G, Li Y, Zhou X, Chen X, Wu Y, He J, Zu X, Shen Y. Yin L, et al. Among authors: chen x. Acta Biochim Biophys Sin (Shanghai). 2023 Nov 25;55(11):1770-1783. doi: 10.3724/abbs.2023142. Acta Biochim Biophys Sin (Shanghai). 2023. PMID: 37700593 Free PMC article.

10

Downregulated circPOKE promotes breast cancer metastasis through activation of the USP10-Snail axis.

Luo Y, Zhu Q, Xiang S, Wang Q, Li J, Chen X, Yan W, Feng J, Zu X. Luo Y, et al. Among authors: chen x. Oncogene. 2023 Oct;42(44):3236-3251. doi: 10.1038/s41388-023-02823-2. Epub 2023 Sep 16. Oncogene. 2023. PMID: 37717099

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

118,738 results

Search Page

Filters